SCHEMBL6481629

SCHEMBL6481629

CON(C)C(=O)c1cc(C)cc(C(=O)c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HPGDS O60760 2/20 0.44
HPGD P15428 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 2/20 0.42
CNR2 P34972 2/20 0.41
CNR1 P21554 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
MEN1 O00255 1/20 0.40
PLA2G1B P04054 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40
GABRA1 P14867 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492606 0.86 ATM (0.60) ATMTDP1L3MBTL1HPGDSHPGD
SCHEMBL6493529 0.85 MLYCD (0.45) ATMTDP1HPGDALDH1A1MEN1
SCHEMBL3303829 0.84 HPGD (0.56) ATMTDP1L3MBTL1HPGDSHPGD
SCHEMBL6479644 0.83 HPGD (0.43) ATMTDP1L3MBTL1HPGDNPC1
SCHEMBL4719735 0.82 TPMT (0.46) ATMHPGDCNR2MLYCD
SCHEMBL15686210 0.82 ATM (0.67) ATMTDP1L3MBTL1HPGDNPC1
SCHEMBL28777 0.80 MLYCD (0.54) HPGDNPC1RAB9AALDH1A1MEN1
SCHEMBL13898624 0.79 MLYCD (0.41) ATMALDH1A1MEN1HTTKMT2A
SCHEMBL2652369 0.79 HPGD (0.57) TDP1HPGDNPC1RAB9AMEN1
SCHEMBL32424912 0.79 HPGD (0.57) TDP1HPGDNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors ZHUANG LINGHANG (US) 2005-01-13 US disclosed
EP-1333831-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-08-13 EP disclosed
WO-2002036734-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors POLI, CYP51A1, DUT ATM 3604/4885TDP1 1008/4885L3MBTL1 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.